Skip to main content
SpringerLink
Log in

Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring

  • Original Article—Alimentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Combined multi-channel intra-luminal impedance and pH (Mll-pH) monitoring can detect gastro-esophageal reflux and identify acid and non-acid reflux (NAR) events. It can be used for patients with persistent symptoms who are having proton pump inhibitor (PPI) therapy. The aim of this study is to determine the frequency of acid reflux and NAR and to establish their relationship with persistent reflux symptoms in Japanese patients with non-erosive reflux disease (NERD) who are on a double-dose of PPI therapy.

Methods

Thirteen patients with NERD, with persistent reflux symptoms, despite taking PPI at least twice daily, were included in this study. Twenty-four-hour combined Mll-pH monitoring was carried out on all patients and reflux episodes were detected by impedance channels, located at 3, 5, 7, 9, 15 and 17 cm above the lower esophageal sphincter (LES) and classified into acid reflux and NAR, based on pH data from 5 cm above the LES. A positive symptom index (SI) was declared, if at least half of the symptoms were preceded by reflux episodes within 5 min.

Results

A total of 916 liquid reflux episodes were detected, and a total of 171 symptoms were recorded. Eight (4.7%) of 171 symptoms were related to acid reflux, and 68 (39.8%) were related to NAR. Seven (53.8%) patients had a positive SI and in these seven patients, a total of 79 symptoms were recorded. 5 (6.3%) of the 79 symptoms were related to acid reflux and 44 (55.7%) were related to NAR.

Conclusions

Persistent reflux symptoms, in SI-positive patients with NERD on double-dose PPI therapy, are more likely to be associated with primarily non-acid reflux.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Richter JE, Bockenek W. Oral pantprazole for erosive esophagitis: a placebo-controlled randomized clinical trial. Pantoprazole US GERD study group. Am J Gastroenterol. 2000;95:3071–80.

    Article  PubMed  CAS  Google Scholar 

  2. Bardhan KD, Hawkey CJ, Long RG, Morgan AG, Wormsley KG, Moules IK, et al. Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group. Aliment Pharmacol Ther. 1995;9:145–51.

    Article  PubMed  CAS  Google Scholar 

  3. Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Am J Gastroenterol. 1996;91:1749–57.

    PubMed  CAS  Google Scholar 

  4. Sharma VK, Leontiadis GI, Howden CW. Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis. Aliment Pharmacol Ther. 2001;15:227–31.

    Article  PubMed  CAS  Google Scholar 

  5. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004;2:656–64.

    Article  PubMed  CAS  Google Scholar 

  6. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease—where next? Aliment Pharmacol Ther. 2005;22:79–94.

    Article  PubMed  CAS  Google Scholar 

  7. Fass R. Persistent heartburn in a patient on proton-pump inhibitor. Clin Gastroenterol Hepatol. 2008;6:393–400.

    Article  PubMed  Google Scholar 

  8. Tutuian R, Vela MF, Shay SS, Castell DO. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol. 2003;37:206–15.

    Article  PubMed  Google Scholar 

  9. Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99:1037–43.

    Article  PubMed  Google Scholar 

  10. Sifrim D, Castell D, Dent J, Kahrilus PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–31.

    Article  PubMed  CAS  Google Scholar 

  11. Johnson LF, DeMeester TR. Twenty-four hour pH monitoring of the in the distal esophagus. Am J Gastroenterol. 1974;62:323–32.

    Google Scholar 

  12. Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–402.

    Article  PubMed  CAS  Google Scholar 

  13. Balaban DH, Yamamoto Y, Liu J, Pehlivanov N, Wisniewski R, DeSilvey D, et al. Sustained esophageal contraction: a marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology. 1999;116:29–37.

    Article  PubMed  CAS  Google Scholar 

  14. Kinoshita Y, Kobayashi T, Kato M, Asahina K, Haruma K, Shimatani T, et al. The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan. J Gastroenterol. 2006;41:554–61.

    Article  PubMed  CAS  Google Scholar 

  15. Shimatani T, Inoue M, Kuroiwa T, Xu J, Mieno H, Nakamura M, et al. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: A crossover comparative study in homozygous extensive metabolizers of cytochrome P4502C19. Clin Pharmacol Ther. 2006;79:144–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology, Nippon Medical School, Sendagi 1-1-5, Bunkyo-ku, Tokyo, 113-8603, Japan

    Katsuhiko Iwakiri, Noriyuki Kawami, Hirohito Sano, Yuriko Tanaka, Mariko Umezawa, Makoto Kotoyori, Yoshio Hoshihara & Choitsu Sakamoto

Authors
  1. Katsuhiko Iwakiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noriyuki Kawami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hirohito Sano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuriko Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mariko Umezawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Makoto Kotoyori
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshio Hoshihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Choitsu Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katsuhiko Iwakiri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwakiri, K., Kawami, N., Sano, H. et al. Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. J Gastroenterol 44, 708–712 (2009). https://doi.org/10.1007/s00535-009-0070-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-009-0070-6

Keywords

Search

Navigation